The price of dental implants is expected to be greatly reduced. The National People's Congress Standing Committee (NPCSC) proposed to expand the collection scope of high-value medical consumables, and collect orthopedic consumables, medicine balloons and dental implants that the masses are concerned about at the national and provincial levels respectively. It is the general trend to bring dental implants into centralized mining. Dental implants are expected to be greatly reduced in price.
The price of dental implants is expected to be greatly reduced 1 1 10/0. Li Keqiang, Premier of the State Council of the People's Republic of China, People's Republic of China (PRC) presided over the the State Council executive meeting and decided to normalize and institutionalize the centralized procurement of drugs and high-value medical consumables to further reduce the medical burden of patients. It is worth noting that the National People's Congress Standing Committee (NPCSC) proposed to expand the collection scope of high-value medical consumables, and collect orthopedic consumables, medicine balloons and dental implants that people are concerned about at the national and provincial levels respectively.
The current centralized national drug procurement began in 20 18, initially piloted in 1 1 city, and expanded to the whole country in the following year. The centralized procurement of drugs, which has attracted much attention because of the sharp drop in drug prices, is also described as "group buying by the whole people", that is, exchanging quantity for market.
In addition to drugs, in recent years, the centralized procurement of high-value medical consumables has also been included in the scope of national centralized procurement. In 2020, the result is to reduce the price of heart stents from tens of thousands of yuan to less than 65438+ 10,000 yuan. In last year's manual joint solicitation, the selected products dropped from an average of 30,000 yuan to less than 1 0,000 pieces, a drop of more than 80%.
According to the statement of this regular meeting, dental implants will also be expected to enter the national and provincial centralized mining scope. Dental implants are one of the typical high-value medical consumables. Lee Hyo Ri, a deputy to the National People's Congress, once described this at the 20021National People's Congress. "In hospitals below the county level, the average cost of dental implant treatment is about 6000-20000 yuan. Planting a mouth is equivalent to buying a suite in the county. "
In fact, since last year, there has been a voice in the industry that dental implants are expected to enter centralized mining. At the National People's Congress, Lee Hyo Ri suggested that dental implants should be included in medical insurance. In this regard, the National Medical Insurance Bureau said that according to the regulations, glasses, dentures, artificial eyes and other devices in various provinces (autonomous regions and municipalities) are not included in the scope of basic medical insurance payment. However, the National Medical Insurance Bureau also mentioned that places with conditions are encouraged to formulate reasonable payment standards according to their own economic development level and fund affordability.
At the local level, in August last year, Ningbo City mentioned in the "Proposal on Further Clarifying the Payment of Medical Insurance Accounts for Dental Implant Projects over the Years" (draft for comment) that it intends to adjust the overall payment standard of medical insurance for dental implant projects. The interpretation at that time was that dental implants were expected to be included in the scope of local collection.
Then, in June last year 165438+ 10/7, Sichuan Medical Machinery Bidding and Purchasing Service Center issued the Notice on Information Collection of Some High-value Dental Medical Consumables. Since then, Zhejiang, Ningxia and other places have also issued similar notices, requesting to fill in the historical procurement data of dental medical consumables. This trend is once again interpreted as that dental implants are expected to be included in the scope of centralized mining.
The National People's Congress Standing Committee (NPCSC) pointed out that in recent years, the reform of centralized procurement of drugs and high-value medical consumables has been continuously promoted, and the market-oriented mechanism has squeezed the inflated medical price, saving more than 260 billion yuan in medical insurance and patient expenses, and also promoting the research and development and quality improvement of domestic pharmaceutical products.
"The next step is to promote the normalization and institutionalization of centralized procurement, and accelerate the expansion to benefit patients." The the National People's Congress Standing Committee (NPCSC) Communique wrote.
According to Xinhua News Agency, on June 5438+1October 10, People's Republic of China (PRC) Li Keqiang, Premier of the State Council of the People's Republic of China presided over the the State Council executive meeting and decided to normalize and institutionalize the centralized procurement of drugs and high-value medical consumables to further reduce the medical burden of patients.
The National People's Congress Standing Committee (NPCSC) suggested expanding the collection scope of high-value medical consumables, and collecting orthopedic consumables, medical balloons and dental implants. Issues of concern to the masses.
Last year, dental implants were included in the pilot exploration of centralized mining in some areas, and now they have been officially confirmed at the national level.
In August last year, Ningbo mentioned in the "Proposal on Further Clarifying the Payment of Medical Insurance Accounts for Dental Implant Projects over the Years" (draft for comment) that it is planned to adjust the overall payment standard of medical insurance for dental implant projects. The interpretation at that time was that dental implants were expected to be included in the scope of local collection.
Last June165438+1October 17, Sichuan Medical Machinery Bidding and Purchasing Service Center issued the Notice on Information Collection of Some High-value Oral Medical Consumables. Since then, Zhejiang, Ningxia and other places have also issued similar notices, requesting to fill in the historical procurement data of dental medical consumables.
Previously, the official media had concentrated on the phenomenon that dental implants were expensive, saying that "no teeth in the world have been hard to look at for a long time" and discussed the feasibility of bringing dental implants into collective mining.
It is the general trend to bring dental implants into centralized mining.
In the second National Conference in 2022, the dust settled when dental implants were included in the collection.
Will the ex-factory price of implants drop sharply?
What impact will this have on the dental industry? The first thing that can be foreseen is the decline in the ex-factory price of dental implants.
According to Zhengguan News, Wei, editor-in-chief of Medical Reform and president of the Institute of Management and Development of Sanyizhiku (Beijing) Hospital, expressed his opinion at the first time after the news of the Standing Committee of the State Council was released: the price increase of dental materials is inevitable.
"Once dental implants are included in centralized mining, it is expected that the price reduction will reach 60%~90%, and different materials and products may have different price reductions."
The ex-factory price of dental implants has dropped significantly, which is conducive to expanding the scale of consumer groups.
Judging from the overall market scale, the number of dental implants in China will be about 4.06 million in 2020, with a compound growth rate of about 30% in the past five years. However, the penetration rate of dental implants in China is still only about 29 per 10,000 people.
What is the lateral contrast of this picture?
It is understood that the penetration rate in South Korea is 5 million/10,000 people, and that in Europe and America is about 2 million/10,000 people. Russia, Brazil and other countries can also reach the level of 100/ 10,000 people. The penetration rate of 29 tablets per 10,000 people in China is lower than that in India.
According to the data of China Stomatology Industry Report 2020, at present, the total number of missing teeth in China has reached 2.642 billion, and the number of potential dental implants is 6.5438+0.888 million. The potential dental implant market scale exceeds 200 billion yuan.
According to China's population base and aging development level, it is conservatively estimated that China's dental implant market still has a growth potential of more than 10 times.
Judging from the current competitive pattern of implant market, 95% of China market is imported products, mainly from European, American and Korean manufacturers, and the localization level is less than 5%.
Localization and promotion of dental implant market
It is understood that the Korean Aochitai brand has the highest market share in China dental implant market, and the largest dental implant brand in Asia has a market share of over 30% in China; The second is Denton in South Korea, with a market share of over 22%. The third market share is the Swiss brand Strohmann, with a market share close to 20%. The most optimistic estimate is that the market share of domestic dental implants is only about 5%.
Compared with imported brands, domestic dental implants have the following differences: the product quality is relatively low, the dentist's recognition is not high, the policy support is weak, and the only advantage is the relatively favorable price.
Now that dental implants are in full swing, favorable policies will help smooth the domestic dental implant sales channels, and bidding will become the battlefield for major manufacturers.
According to the research report of Guohai Securities, there are dozens of implant manufacturers in China at present, mainly including Huaxi Stomatological Hospital, Beijing Leiden, Gaoweijie Likang, Dabo Baichitai, Jiangsu Chuangying (represented by Zhenghai Bio), Kangtuo Medical, Ningbo Meizhen, Changzhou Baikangte, Shenzhen Ante and Kerunxi. Among them, the company with large volume is expected to have an annual revenue of around 50 million.
Ultimately, consumers benefit a lot.
It is understood that the current terminal price of a dental implant is generally between 6000-20000 yuan. In 2020, the per capita disposable income of the national residents will be 32 1.89 yuan, and the annual income will only grow by two teeth.
Zhou Xuedong, chief physician of West China College of Stomatology, revealed that the most expensive dental implant in this hospital costs 80,000 yuan. If you plant a full mouth, it is equivalent to having a high-profile BMW in your mouth.
Although the price of dental implant medical services may not drop significantly, the popularization of centralized procurement will greatly reduce the ex-factory price of dental implants.
Consumers who are transmitted to the terminal are expected to be relieved of their dilemma of "not looking at toothache, but feeling distressed after reading it".
The price of dental implants is expected to drop significantly in March 65438+ 10/0. Li Keqiang, Premier of the State Council of the People's Republic of China, People's Republic of China (PRC) presided over the the State Council executive meeting and decided to normalize and institutionalize the centralized procurement of drugs and high-value medical consumables to further reduce the medical burden of patients.
The meeting pointed out that in recent years, the reform of centralized procurement of drugs and high-value medical consumables has been continuously promoted, and the market-oriented mechanism has effectively squeezed the inflated medical prices. By the end of 20021,the accumulated savings in medical insurance and patient expenses were 260 billion yuan, which also promoted pharmaceutical enterprises to devote more energy to product research and development and quality improvement. In the next step, it is necessary to promote the normalization and institutionalization of centralized quantity procurement, speed up the expansion, and continuously reduce the price of drugs to benefit patients.
The reporter noted that 202 1 1 the State Council General Office issued "Opinions on Promoting Normalization and Institutionalization of Centralized Drug Purchase".
The opinion puts forward that it is necessary to improve the market-oriented drug price formation mechanism, give play to the strategic procurement role of medical insurance fund, promote the normalization and institutionalization of centralized drug procurement, improve the working mechanism of government organization, alliance procurement and platform operation, guide the drug price to return to a reasonable level, and effectively reduce the drug burden of the masses.
Continue to promote the centralized procurement of state-level drugs focusing on chronic diseases and common diseases.
The executive meeting of the State Council pointed out that it is necessary to focus on chronic diseases and common diseases, continue to promote centralized drug procurement at the national level, and carry out provincial or inter-provincial alliance procurement for drugs outside the scope of centralized national drug procurement. By the end of this year, the total number of drugs collected at the national and provincial levels has reached more than 350 in each province.
Wei, editor-in-chief of "Medical Reform" and dean of the Management Development Research Institute of Sanyizhiku (Beijing) Hospital, told reporters that when drugs for chronic diseases and common diseases are included in centralized procurement, ordinary residents will have more obvious feelings about reducing the drug burden. For example, chronic diseases basically require long-term medication, and the inclusion of centralized procurement may benefit more patients and win patients' support for policies.
How helpful is it to reduce the burden of patients' medication by purchasing drugs collected overseas in the province or across provinces?
The reporter noted that in 2002110, the leading group for medical reform in the State Council issued the "Implementation Opinions on Deepening the Reform of Medical and Health System by Deeply Popularizing the Experience of Sanming City in Fujian Province", proposing to normalize and institutionalize the centralized procurement of pharmaceutical consumables organized by the state, gradually expand the scope of procurement, and strive to purchase more than 300 generic names of drugs by the end of 2022. By the end of the 14th Five-Year Plan period, the number of generic drugs purchased by each province, state and provincial organizations should exceed 500.
Wei said that for the National Medical Insurance Bureau, if all the drugs in the medical insurance catalogue are included in centralized procurement at this stage, first, there may not be so much energy, and second, not every drug needs to be led by the National Medical Insurance Bureau.
Because the characteristics of drugs used in different regions are different, for example, drugs used in Tibet and Qinghai are not necessarily commonly used in Guangdong, while there is thalassemia in Guangdong, and the drugs used here are not necessarily commonly used in other provinces.
Take brucellosis as an example. Only in Qinghai, Xinjiang, Inner Mongolia, Ningxia, Gansu, Shaanxi and other places with many sheep can patients suffer from this disease. Related drugs will be used in these areas, but may not be used in other areas. In this case, several provinces and regions in the west need to unite to purchase.
"In other words, it is more targeted to purchase drugs collected overseas in provincial or inter-provincial alliances." Wei said that because of the huge market in China, it is definitely ideal to reduce the purchasing price of intra-provincial or inter-provincial alliances.
Collect national and provincial orthopedic consumables and dental implants respectively.
The State Council executive meeting also pointed out that it is necessary to gradually expand the coverage of centralized procurement of high-value medical consumables, and carry out centralized procurement of orthopedic consumables, medical balloons and dental implants. , respectively, by the national and provincial people's attention.
The reporter found out that this is the first time that dental implants have been intensively mined at the national level.
In September, 20021,the National Medical Insurance Bureau made it clear that glasses, dentures, artificial eyes and other devices would not be included in the basic medical insurance payment scope at present, in response to the proposal put forward by Lee Hyo Ri, a representative of the National People's Congress.
Wei said that the current dental implant market in China is very abnormal, which may be far more abnormal than heart stents. The data shows that the price of a dental implant is between 6000 yuan and 20000 yuan. With the consumables such as heart stents and artificial joints being included in the national collection, the price reduction effect is obvious, and the voice of dental implants being included in medical insurance is getting higher and higher.
According to the national centralized procurement plan, only drugs and consumables in medical insurance can be included in centralized procurement. In its reply to this suggestion, the National Medical Insurance Bureau did not explicitly carry out dental implant collection.
However, the National Medical Insurance Bureau also pointed out in this reply that it will standardize the price items of oral medical services and integrate and split too many items. Control the medical service items and charging standards of public hospitals. Guide local areas to include implants in the scope of platform hanging nets, promote the transparency of implant prices of various brands, and squeeze out water.
It is generally believed in the industry that this means that high-priced consumables such as dental implants are expected to enter the medical insurance payment in some areas. The executive meeting of the State Council directly and clearly pointed out that dental implants concerned by the masses were collected at the national and provincial levels respectively.
Wei Zining said, "Once dental implants are incorporated into collective mining, the price reduction is expected to reach 60%~90%, and different materials and products may have different price reductions."
In addition, this executive meeting also pointed out that the long-term stable supply of selected drugs and consumables should be ensured, and supervision should be strengthened to ensure that the price reduction of selected products will not be downgraded. Medical institutions should give reasonable priority to the use of selected products. At the same time, implement the policy of retaining the balance of centralized medical insurance fund, promote the reform of salary system, reasonably increase the income of medical staff and better mobilize their enthusiasm.